June 2003 Bulletin

In Brief

FDA grants marketing clearance for antibiotic bone cement

On May 6, the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) cleared the first antibiotic bone cement preparation.  The FDA noted that the indication for use of this product is for the fixation of prostheses to living bone for use in the second stage of a two-stage revision for total joint arthroplasty.  During the past several years, the AAOS has been involved in on-going dialogue with the FDA, including interactions in the Orthopaedic Device Forum, of which the AAOS is an active participant, to encourage FDA approval of antibiotic bone cement in the United States.  For further information, e-mail Jeanie Kennedy of the AAOS department of research and scientific affairs, at kennedy@aaos.org.  

AAOS seeking Diversity Award nominations

AAOS is seeking nominations for the 2004 Diversity Award, which recognizes Academy Fellows who have contributed to advancing diversity in orthopaedics through recruiting, mentoring, leadership or the treatment of diverse populations. Examples of qualifying activities include teaching culturally competent care in a clinical or institutional setting; sponsoring, mentoring or guiding young orthopaedists, culturally diverse and female medical students; and staffing clinics that provide musculoskeletal care for underserved U.S. populations. Nominations may be submitted by any Academy Fellow in good standing, a female resident or an orthopaedic resident of an underrepresented ethnicity who has directly and professionally benefited from the nominee’s activities, or a member in good standing of the Academic Orthopaedic Society. Please complete the nomination form and provide requested supporting materials to the AAOS no later than Sept. 8, 2003. For more information, visit www.aaos.org/diversity under the News & Events tab or contact AAOS customer service at (800) 626-6726.

AAOS helps establish clinical performance measures for OA Knee

Osteoarthritis (OA) is one of the chronic conditions included in the Doctor’s Office Quality Project of the Centers for Medicare and Medicaid Services. Over the past year, the AAOS has been working with the AMA Physician’s Consortium for Performance Improvement, as well as other groups with osteoarthritis expertise, to identify key performance measures for the treatment of osteoarthritis of the knee. The measures have now been approved for dissemination. AAOS members are encouraged to review, share, use and encourage usage of these measures by any physicians who treat OA Knee. For more information, contact Belinda Duszynski, staff liaison to the Evidence-Based Practice Committee, at duszynski@aaos.org. Review the official Clinical Performance Measures for OA Knee, on the AAOS Web site.

Reduce medical errors by creating blame-free environment says JCAHO

Speaking before the U.S. Senate Committee on Governmental Affairs on June 12, Dennis S. O’Leary, MD, president of the Joint Commission on Accreditation of Healthcare Organizations, outlined six strategies to create a culture of patient safety within healthcare institutions. He emphasized that Congress, healthcare providers and purchasers need to work together to:

Orthopaedic surgeons under age 35 hard to find in Pennsylvania

Orthopaedic surgeons under age 35 in private practice are "virtually extinct" in Pennsylvania according to a survey by the American Medical Association, which found just four in the entire state, one of whom is planning to leave. Nearly 75 percent of orthopaedic residents who trained in the state between 1998 and 2002 left after they completed their education. Reasons for the exodus include the high cost of medical liability insurance and the litigious environment in the state. According to the Federation of State Medical Boards’ report, between 2001 and 2002 nearly 1,100 Pennsylvania practicing physicians left the state ranks.

Home Previous Page